We have previously shown that global and liver-specific Bmal1 deficient mice develop enhanced atherosclerosis. Macrophages play a critical role in atherosclerosis, yet the role of macrophage Bmal1 in cholesterol uptake, intracellular transport and atherosclerosis remains unknown. Here, we used global and macrophage-specific Bmal1 deficient mice to clarify the role of macrophage Bmal1 in atherosclerosis. We found that macrophage-specific Bmal1 deficient mice show increased atherosclerosis. Mechanistically, Bmal1 deficient macrophages exhibited: (1) increased expression of Lox-1 and Cd36 and uptake of oxLDL; (2) decreased expression of Abca1 and Abcg1 and reduced cholesterol efflux, and reverse cholesterol transport; and (3) diminished export of free cholesterol from lysosomes due to reduced expression of Npc1 and Npc2. Molecular studies showed that Bmal1 directly regulates Npc1 and Npc2 by binding to E-boxes in their promoters, whereas it indirectly regulates Abca1 and Abcg1 by regulating ZNF202. Furthermore, we provide evidence that Bmal1 interacts with both Clock and Npas2 to regulate ZNF202, Npc1 and Npc2. Our data demonstrate that macrophage Bmal1 is a key regulator of oxLDL uptake, lysosomal cholesterol export, and cholesterol efflux, and, therefore, plays a crucial role in the prevention of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: